journal article·2018-11-05Open access

Effect of artificial cell miniaturization on urea degradation by immobilizedE. coliDH5α (pKAU17)

Ricardo Duque, Yiming Shan, Monica Joya, Nandini Ravichandran, Berok Asi, Maryam Mobed-Miremadi, Scott Mulrooney, Melanie McNeil, Satya Prakash

Abstract

Second generation E. coli DH5α (pKAU17) was successfully encapsulated by means of atomization (MA), inkjet printing (MI) and double-encapsulation (DDMI) for the purpose of urea degradation in a simulated uremic medium at 37 °C. Experimentally determined values of the effectiveness factor are 0.83, 0.28 and 0.34 for the MI, MA and DDMI capsules, respectively, suggesting that the catalytic activity of the E. coli DH5α (pKAU17) immobilized in MI capsule (d = 52 μm ± 2.7 μm) is significantly less diffusion-limited than in the case of the MA (d = 1558 μm ± 125 μm) and DDMI (d = 1370 μm ± 60 μm) bio-encapsulation schemes at the 98.3% CI. The proposed novel double encapsulation biofabrication method for alginate-based microspheres, characterized by lower membrane degradation rates due to secondary containment is recommended compared to the standard atomization scheme currently adopted across immobilization-based therapeutic scenarios. A Fickian-based mechanism is proposed with simulations mimicking urea degradation for a single capsule for the atomization and the inkjet schemes.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: 3D Printing in Biomedical Research · Pancreatic function and diabetes · Tissue Engineering and Regenerative Medicine

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Western Digital, San Jose, CA, USA;

Intuitive Surgical, Sunnyvale, CA, USA;

Intuity Medical, Sunnyvale, CA, USA;

Roche Sequencing Solutions, Pleasanton, CA, USA;

Genentech, South San Francisco, CA, USA;

Department of Bioengineering, Santa Clara University, Santa Clara, CA, USA;

Microbiology and Molecular Genetics, Michigan State University, East Lansing, MI, USA;

Department of Biomedical, Chemical and Materials Engineering, San Jose State University, San Jose, CA, USA;

Department of Biomedical Engineering, McGill University, Montreal, Quebec, Canada

References (63)

Show source-provided references
1. 10.1142/9789812770370_000610.1142/9789812770370_0006 ↗
2. Chang TMS. Selected topics in nanomedicine. Regenerative Med, Artificial Cells Nanomed. 2013;3411–428.10.1142/8776 ↗
3. Chang TMS · J Nanosci Curr · 2016 · 1 · 102
4. 10.1017/S000711451100470310.1017/S0007114511004703 ↗
5. 10.1002/sctm.16-011610.1002/sctm.16-0116 ↗
6. 10.3727/096368912X63749710.3727/096368912X637497 ↗
7. 10.1038/nm0896-88310.1038/nm0896-883 ↗
8. 10.1007/s00253-012-4651-610.1007/s00253-012-4651-6 ↗
9. 10.1002/bit.26046061510.1002/bit.260460615 ↗
10. Thomas Ming Swi C. · 2013 · 411
11. 10.1098/rsif.2013.056610.1098/rsif.2013.0566 ↗
12. 10.1039/C6LC00261G10.1039/C6LC00261G ↗
13. 10.1002/smll.20110246410.1002/smll.201102464 ↗
14. 10.3390/bioengineering403006410.3390/bioengineering4030064 ↗
15. 10.1007/s10544-009-9363-z10.1007/s10544-009-9363-z ↗
16. 10.3109/02652048.2013.81472610.3109/02652048.2013.814726 ↗
17. Zahn JD. · 2010
18. 10.1039/c3lc50678a10.1039/c3lc50678a ↗
19. 10.1088/1758-5082/6/2/02410410.1088/1758-5082/6/2/024104 ↗
20. 10.1115/1.315332610.1115/1.3153326 ↗
21. 10.1016/j.ijpharm.2012.01.05010.1016/j.ijpharm.2012.01.050 ↗
22. 10.1021/bm700565h10.1021/bm700565h ↗
23. Andersen T · Chem · 2012 · 37 · 227
24. 10.1002/bit.26033011210.1002/bit.260330112 ↗
25. 10.3109/1073119910911784710.3109/10731199109117847 ↗
26. 10.1016/j.biomaterials.2009.01.03410.1016/j.biomaterials.2009.01.034 ↗
27. 10.1021/bm049813w10.1021/bm049813w ↗
28. 10.1016/S0142-9612(00)00106-X10.1016/S0142-9612(00)00106-X ↗
29. 10.3390/ma604128510.3390/ma6041285 ↗
30. 10.1002/jbm.a.3049210.1002/jbm.a.30492 ↗
31. 10.3390/ma703208710.3390/ma7032087 ↗
32. Shan Y. · 2011
33. 10.1038/nm.403010.1038/nm.4030 ↗
34. 10.3109/10731199.2012.71606410.3109/10731199.2012.716064 ↗
35. Smith JM. · 1970
36. Fournier RL. · 201110.1201/b14885 ↗
37. 10.1099/00221287-135-6-176910.1099/00221287-135-6-1769 ↗
38. 10.1128/JB.174.13.4324-4330.199210.1128/JB.174.13.4324-4330.1992 ↗
39. 10.1039/b903311d10.1039/b903311d ↗
40. 10.1002/bit.2211910.1002/bit.22119 ↗
41. 10.3109/1073119890911828510.3109/10731198909118285 ↗
42. 10.3109/10731199.2011.57463710.3109/10731199.2011.574637 ↗
43. Guyton AC. · 1991
44. King M · 2011
45. 10.4236/jsemat.2013.34A100110.4236/jsemat.2013.34A1001 ↗
46. 10.1002/1097-4636(200108)56:2<228::AID-JBM1089>3.0.CO;2-910.1002/1097-4636(200108)56:2<228::AID-JBM1089>3.0.CO;2-9 ↗
47. 10.1016/j.addr.2007.03.01210.1016/j.addr.2007.03.012 ↗
48. 10.3891/acta.chem.scand.21-285910.3891/acta.chem.scand.21-2859 ↗
49. 10.1016/j.carbpol.2008.01.00710.1016/j.carbpol.2008.01.007 ↗
50. 10.1007/978-3-540-92679-510.1007/978-3-540-92679-5 ↗
51. Chang TM · Methods Molecul Biol · 1997 · 63 · 343
52. 10.1002/aic.69047121310.1002/aic.690471213 ↗
53. 10.1016/j.watres.2013.01.04410.1016/j.watres.2013.01.044 ↗
54. 10.3390/membranes403031910.3390/membranes4030319 ↗
55. 10.1021/acsami.5b0552910.1021/acsami.5b05529 ↗
56. 10.1016/j.memsci.2017.09.01010.1016/j.memsci.2017.09.010 ↗
57. 10.3109/21691401.2014.89762910.3109/21691401.2014.897629 ↗
58. 10.3390/ma712767010.3390/ma7127670 ↗
59. 10.1002/adfm.20130365510.1002/adfm.201303655 ↗
60. Motealleh B · J Biomed Mater Res · 2014 · 102 · 97710.1002/jbm.b.33078 ↗
61. 10.3389/fbioe.2017.0002310.3389/fbioe.2017.00023 ↗
62. 10.1007/s10439-016-1612-810.1007/s10439-016-1612-8 ↗
63. 10.1016/j.msec.2017.09.00210.1016/j.msec.2017.09.002 ↗